Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,195 CAD | -7,14% | 0,00% | +34,48% |
Vakgebied
Aantal werknemers: 44
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Delivery (Services)
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +533,52% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Europe
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +533,52% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Anthony Tennyson
FOU | Founder | - | 01-01-20 |
Jonathan Held
FOU | Founder | 38 | 01-04-20 |
Shaun McNulty
CTO | Chief Tech/Sci/R&D Officer | - | - |
James Collins
COO | Chief Operating Officer | - | - |
David Nutt
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 17-05-22 | |
Gordo Whittaker
IRO | Public Communications Contact | - | - |
Naomi Junghae
HRO | Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Carter
BRD | Director/Board Member | 63 | 14-12-21 |
Stephen Page
BRD | Director/Board Member | - | - |
George Scorsis
FOU | Founder | - | - |
Anthony Tennyson
FOU | Founder | - | 01-01-20 |
Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 38 591 197 | 35 330 516 ( 91,55 %) | 0 | 91,55 % |
Bedrijfsgegevens
Awakn Life Sciences Corp.
217 Queen Street West Suite 301
M5V 0R2, Toronto
+
http://www.awaknlifesciences.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,48% | 5,66 mln. | |
+41,79% | 54,04 mld. | |
-0,56% | 41,92 mld. | |
+49,17% | 41,96 mld. | |
-7,20% | 28,35 mld. | |
+12,59% | 26,35 mld. | |
-21,51% | 19 mld. | |
+6,92% | 13 mld. | |
+24,91% | 12,19 mld. | |
+29,60% | 12,28 mld. |
- Beurs
- Aandelen
- Koers AWKN
- Onderneming Awakn Life Sciences Corp.